Cargando…
Whole Transcriptome Signature for Prognostic Prediction (WTSPP): application of whole transcriptome signature for prognostic prediction in cancer
Developing prognostic biomarkers for specific cancer types that accurately predict patient survival is increasingly important in clinical research and practice. Despite the enormous potential of prognostic signatures, proposed models have found limited implementations in routine clinical practice. H...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483260/ https://www.ncbi.nlm.nih.gov/pubmed/32144347 http://dx.doi.org/10.1038/s41374-020-0413-8 |
_version_ | 1783580910266875904 |
---|---|
author | Schaafsma, Evelien Zhao, Yanding Wang, Yue Varn, Frederick S. Zhu, Kenneth Yang, Huan Cheng, Chao |
author_facet | Schaafsma, Evelien Zhao, Yanding Wang, Yue Varn, Frederick S. Zhu, Kenneth Yang, Huan Cheng, Chao |
author_sort | Schaafsma, Evelien |
collection | PubMed |
description | Developing prognostic biomarkers for specific cancer types that accurately predict patient survival is increasingly important in clinical research and practice. Despite the enormous potential of prognostic signatures, proposed models have found limited implementations in routine clinical practice. Herein, we propose a generic, RNA sequencing platform-independent, statistical framework named Whole Transcriptome Signature for Prognostic Prediction (WTSPP) to generate prognostic gene signatures. Using ovarian cancer and lung adenocarcinoma as examples, we provide evidence that our prognostic signatures over-perform previous reported signatures, capture prognostic features not explained by clinical variables and expose biologically relevant prognostic pathways, including those involved in the immune system and cell cycle. Our approach demonstrates a robust method for developing prognostic gene expression signatures. In conclusion, our statistical framework can be generally applied to all cancer types for prognostic prediction and might be extended to other human diseases. The proposed method is implemented as an R package (PanCancerSig) and is freely available on GitHub (https://github.com/Cheng-Lab-GitHub/PanCancer_Signature). |
format | Online Article Text |
id | pubmed-7483260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-74832602020-09-21 Whole Transcriptome Signature for Prognostic Prediction (WTSPP): application of whole transcriptome signature for prognostic prediction in cancer Schaafsma, Evelien Zhao, Yanding Wang, Yue Varn, Frederick S. Zhu, Kenneth Yang, Huan Cheng, Chao Lab Invest Article Developing prognostic biomarkers for specific cancer types that accurately predict patient survival is increasingly important in clinical research and practice. Despite the enormous potential of prognostic signatures, proposed models have found limited implementations in routine clinical practice. Herein, we propose a generic, RNA sequencing platform-independent, statistical framework named Whole Transcriptome Signature for Prognostic Prediction (WTSPP) to generate prognostic gene signatures. Using ovarian cancer and lung adenocarcinoma as examples, we provide evidence that our prognostic signatures over-perform previous reported signatures, capture prognostic features not explained by clinical variables and expose biologically relevant prognostic pathways, including those involved in the immune system and cell cycle. Our approach demonstrates a robust method for developing prognostic gene expression signatures. In conclusion, our statistical framework can be generally applied to all cancer types for prognostic prediction and might be extended to other human diseases. The proposed method is implemented as an R package (PanCancerSig) and is freely available on GitHub (https://github.com/Cheng-Lab-GitHub/PanCancer_Signature). 2020-03-06 2020-10 /pmc/articles/PMC7483260/ /pubmed/32144347 http://dx.doi.org/10.1038/s41374-020-0413-8 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Schaafsma, Evelien Zhao, Yanding Wang, Yue Varn, Frederick S. Zhu, Kenneth Yang, Huan Cheng, Chao Whole Transcriptome Signature for Prognostic Prediction (WTSPP): application of whole transcriptome signature for prognostic prediction in cancer |
title | Whole Transcriptome Signature for Prognostic Prediction (WTSPP): application of whole transcriptome signature for prognostic prediction in cancer |
title_full | Whole Transcriptome Signature for Prognostic Prediction (WTSPP): application of whole transcriptome signature for prognostic prediction in cancer |
title_fullStr | Whole Transcriptome Signature for Prognostic Prediction (WTSPP): application of whole transcriptome signature for prognostic prediction in cancer |
title_full_unstemmed | Whole Transcriptome Signature for Prognostic Prediction (WTSPP): application of whole transcriptome signature for prognostic prediction in cancer |
title_short | Whole Transcriptome Signature for Prognostic Prediction (WTSPP): application of whole transcriptome signature for prognostic prediction in cancer |
title_sort | whole transcriptome signature for prognostic prediction (wtspp): application of whole transcriptome signature for prognostic prediction in cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483260/ https://www.ncbi.nlm.nih.gov/pubmed/32144347 http://dx.doi.org/10.1038/s41374-020-0413-8 |
work_keys_str_mv | AT schaafsmaevelien wholetranscriptomesignatureforprognosticpredictionwtsppapplicationofwholetranscriptomesignatureforprognosticpredictionincancer AT zhaoyanding wholetranscriptomesignatureforprognosticpredictionwtsppapplicationofwholetranscriptomesignatureforprognosticpredictionincancer AT wangyue wholetranscriptomesignatureforprognosticpredictionwtsppapplicationofwholetranscriptomesignatureforprognosticpredictionincancer AT varnfredericks wholetranscriptomesignatureforprognosticpredictionwtsppapplicationofwholetranscriptomesignatureforprognosticpredictionincancer AT zhukenneth wholetranscriptomesignatureforprognosticpredictionwtsppapplicationofwholetranscriptomesignatureforprognosticpredictionincancer AT yanghuan wholetranscriptomesignatureforprognosticpredictionwtsppapplicationofwholetranscriptomesignatureforprognosticpredictionincancer AT chengchao wholetranscriptomesignatureforprognosticpredictionwtsppapplicationofwholetranscriptomesignatureforprognosticpredictionincancer |